🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseMASH prevalence in GLP-1 users — November 2025 Page 4

MASH prevalence in GLP-1 users — November 2025

tampaLisa73 Wed, Jun 4, 2025 at 3:50 AM 44 replies 2,251 viewsPage 4 of 9
pete_nash
Member
312
1,345
Aug 2024
Nashville, TN
Jun 6, 2025 at 3:15 PM#16

From the other side of the consultation, briefly. The mechanism and the magnitude are separate questions. Agreeing that something happens says nothing about whether it happens enough to act on.

4 2Admin, Dr.Martinez, mike_mod and 1 other
Reply Quote Save Share Report
MounjBrad
Member
278
890
Oct 2024
Kentucky
Jun 6, 2025 at 6:33 PM#17
pete_nash said:
The mechanism and the magnitude are separate questions.

I read this differently. The confidence in this thread is running ahead of the evidence, and I would rather the uncertainty were stated than smoothed over because it is unsatisfying.

5 3ben_calgary, patPC_UT, Dr.DermMIA and 2 others
Reply Quote Save Share Report
hans_munich
Member
534
2,345
Jul 2024
Munich, DE
Jun 6, 2025 at 9:51 PM#18
pete_nash said:
The mechanism and the magnitude are separate questions.

No disagreement, though the timescale matters more than the mechanism here. Most of what looks like a difference in kind turns out to be a difference in how long somebody waited.

6 4Dr.LipidDallas, alex_tucson, kevin_tulsa and 3 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Jun 7, 2025 at 1:09 AM#19
pete_nash said:
The mechanism and the magnitude are separate questions.

That reframing is the part I needed.

7 5Dr.PulmRoch, maya_sedona, stefan_berlin and 4 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Jun 7, 2025 at 4:27 AM#20

Moderator note: a post naming a supplier has been edited. Discuss suppliers in the review sections, not here. Carry on.

Last edited: Jun 7, 2025 at 6:27 AM
29 2PurityPaulOR, MaxMetOK, MounjBrad and 26 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register